14 Jones Case Studies Reviewed
Foucauldian Discourse Analysis (FDA) Willig (2008)
DATA MONITORING COMMITTEES: A Regulator’s Perspective Mary A. Foulkes, Ph.D. Office of Biostatistics and Epidemiology Center for Biologics Evaluation and.
Clinical Review Process: An FDA Perspective Karen Midthun, M.D. Deputy Director of Medicine Center for Biologics Evaluation and Research FDA April 15,
World Health Organization International Biological Standards Elwyn Griffiths Biologics and Genetic Therapies Directorate.
New Developments in Cancer Treatment Dulcinea Quintana, MD.
World Health Organization International Biological Standards
Dengue Virus and Its Risk to the U.S. Blood Supply
2013 Spring MS Connection
